Compare SGD & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SGD | PTHL |
|---|---|---|
| Founded | 2021 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.8M |
| IPO Year | N/A | 2024 |
| Metric | SGD | PTHL |
|---|---|---|
| Price | $0.42 | $0.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 724.1K | 106.4K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,970,752.00 | $448,196.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2770.15 | N/A |
| 52 Week Low | $0.64 | $0.47 |
| 52 Week High | $3.03 | $32.00 |
| Indicator | SGD | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 24.91 | 37.66 |
| Support Level | $0.74 | $0.50 |
| Resistance Level | $1.22 | $0.63 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 2.16 | 30.82 |
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.